Fernández-Guasti A, Rodríguez-Manzo G
Departamento de Farmacología y Toxicología, CINVESTAV, México D.F.
Pharmacol Biochem Behav. 1992 Jul;42(3):529-33. doi: 10.1016/0091-3057(92)90150-e.
To explore whether the inhibitory actions of endogenous serotonin on rat male sexual behavior were mediated via the stimulation of the 5-hydroxytryptamine1A (5-HT1A) or 5-HT1B receptor subtypes, two series of studies were undertaken. In the first series, an attempt to block the inhibitory actions of threshold doses of the serotonin precursor 5-hydroxytryptophan (5-HTP, 50 mg/kg) by administering the beta-5-HT antagonist alprenolol (5.0 mg/kg) and the selective beta-blocker practolol (0.5 mg/kg) was made. Both antagonists effectively prevented, at least partially, the inhibitory actions of 5-HTP. In the second series, a possible synergistic effect of a subthreshold dose of 5-HTP (12.5 mg/kg) with low doses of the selective 5-HT1B agonist 1-(m-trifluoro-methylphenyl)piperazine (TFMPP,0.125 mg/kg) or the selective 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT, 0.0625 mg/kg) was investigated. A clear synergistic inhibitory effect of 5-HTP with TFMPP was observed. All data are interpreted based upon the hypothesis suggesting a physiological inhibitory role of the 5-HT1B receptor subtype on male rat sexual behavior.
为了探究内源性5-羟色胺对雄性大鼠性行为的抑制作用是否通过刺激5-羟色胺1A(5-HT1A)或5-HT1B受体亚型介导,我们进行了两个系列的研究。在第一个系列中,尝试通过给予β-5-HT拮抗剂阿普洛尔(5.0毫克/千克)和选择性β-阻滞剂心得宁(0.5毫克/千克)来阻断5-羟色胺前体5-羟色氨酸(5-HTP,50毫克/千克)阈剂量的抑制作用。两种拮抗剂均至少部分有效地阻止了5-HTP的抑制作用。在第二个系列中,研究了阈下剂量的5-HTP(12.5毫克/千克)与低剂量的选择性5-HT1B激动剂1-(间三氟甲基苯基)哌嗪(TFMPP,0.125毫克/千克)或选择性5-HT1A激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT,0.0625毫克/千克)之间可能的协同作用。观察到5-HTP与TFMPP有明显的协同抑制作用。所有数据均基于5-HT1B受体亚型对雄性大鼠性行为具有生理抑制作用这一假设进行解释。